Swiss All Share Index
15.591,90
PKT
-150,35
PKT
-0,96
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
10.02.22 | DocMorris Buy | Jefferies & Company Inc. | |
10.02.22 | Zurich Insurance Hold | Jefferies & Company Inc. | |
10.02.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
10.02.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
10.02.22 | UBS Underweight | JP Morgan Chase & Co. | |
09.02.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
09.02.22 | Novartis Neutral | UBS AG | |
09.02.22 | Novartis Equal-weight | Morgan Stanley | |
09.02.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
09.02.22 | ams-OSRAM Underweight | Barclays Capital | |
09.02.22 | ams-OSRAM Hold | Deutsche Bank AG | |
09.02.22 | Roche Buy | Deutsche Bank AG | |
09.02.22 | Swiss Re Hold | Jefferies & Company Inc. | |
09.02.22 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
09.02.22 | ams-OSRAM Neutral | Credit Suisse Group | |
08.02.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
08.02.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
08.02.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
08.02.22 | Swiss Re Underweight | Morgan Stanley | |
08.02.22 | Zurich Insurance Equal-weight | Morgan Stanley | |
08.02.22 | ams-OSRAM Neutral | UBS AG | |
08.02.22 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
07.02.22 | Holcim Hold | Jefferies & Company Inc. | |
07.02.22 | Roche Buy | Deutsche Bank AG | |
07.02.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
07.02.22 | Roche Overweight | Barclays Capital | |
07.02.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
07.02.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
04.02.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.02.22 | Roche Overweight | Barclays Capital | |
04.02.22 | Roche Neutral | UBS AG | |
04.02.22 | Nestlé Buy | UBS AG | |
04.02.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
04.02.22 | Givaudan Neutral | UBS AG | |
04.02.22 | Holcim Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.02.22 | Novartis Neutral | UBS AG | |
03.02.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
03.02.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
03.02.22 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
03.02.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research |